Search Results - "Linn SC"

A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer.

Authors: Sollfrank, L Linn, SC Hauptmann, M et al.

Source: BMC Medical Research Methodology. 6/29/2023, Vol. 23 Issue 1, p1-10. 10p.

Correction: A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer.

Authors: Sollfrank, L Linn, SC Hauptmann, M et al.

Source: BMC Medical Research Methodology. 9/8/2023, Vol. 23 Issue 1, p1-1. 1p.

Isolated tumor cells in breast cancer.

Authors: Sonke GS Linn SC

Source: New England Journal of Medicine. 11/12/2009, Vol. 361 Issue 20, p1995-1996. 2p.

Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.

Authors: Retèl VP Joore MA Knauer M et al.

Source: European Journal of Cancer. May2010, Vol. 46 Issue 8, p1382-1391. 10p.

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Authors: Seefat RL Vliek SB de Jong VMT et al.

Source: The Lancet. Oncology [Lancet Oncol] 2026 Jul; Vol. 27 (7), pp. 795-807.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.

Authors: Mauritz AJW de Munck L Simons JM et al.

Source: The Lancet. Oncology [Lancet Oncol] 2026 Jul; Vol. 27 (7), pp. 808-816.

Publication Type: Journal Article; Multicenter Study; Observational Study

Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study.

Authors: Meijer J Hermanns N Bijlsma R et al.

Source: International journal of cancer [Int J Cancer] 2026 Jun 04. Date of Electronic Publication: 2026 Jun 04.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE

Immunohistochemical biomarkers to predict adjuvant chemotherapy response in patients with early breast cancer in the MATADOR trial (BOOG 2005-02).

Authors: Opdam M Ultee N Geenen JJJ et al.

Corporate Authors: Opdam M Ultee N Geenen JJJ et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2026 Jun; Vol. 87, pp. 104749. Date of Electronic Publication: 2026 Mar 13.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

Towards patient-centered research in pregnancy-associated breast cancer: creating a science agenda through a priority-setting-partnership.

Authors: Bakhuis CFJ Koning AS Suelmann BBM et al.

Source: Breast (Edinburgh, Scotland) [Breast] 2026 May 15; Vol. 88, pp. 104808. Date of Electronic Publication: 2026 May 15.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

Authors: Voorthuis RAB Oliveira M van Rossum AGJ et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2026 May 15; Vol. 32 (10), pp. 1983-1994.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Coverage with evidence development programs: a scoping review on characteristics and patient access.

Authors: Verbeek JGE Seefat RL Wilthagen EA et al.

Source: Health policy (Amsterdam, Netherlands) [Health Policy] 2026 Sep; Vol. 171, pp. 105615. Date of Electronic Publication: 2026 Mar 24.

Publication Type: Journal Article; Scoping Review; Review

Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8409431 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-6054 (Electronic) Linking ISSN: 01688510 NLM ISO Abbreviation: Health Policy Subsets: MEDLINE

Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival.

Authors: Wang Y Drubay D Jonas SF et al.

Corporate Authors: Wang Y Drubay D Jonas SF et al.

Source: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2026 Apr 21. Date of Electronic Publication: 2026 Apr 21.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Pathway activity profiling can predict neoadjuvant endocrine therapy response in HR+ HER2- postmenopausal early stage breast cancer.

Authors: de Gruil N de Groot AF Wesseling-Rozendaal Y et al.

Source: Breast cancer research : BCR [Breast Cancer Res] 2026 Feb 25; Vol. 28 (1). Date of Electronic Publication: 2026 Feb 25.

Publication Type: Journal Article; Randomized Controlled Trial

Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

Three-year patient-reported outcomes of the BOOG 2013-08 RCT evaluating omission of sentinel lymph node biopsy in early-stage breast cancer patients treated with breast conserving surgery: Impact of personality traits on health-related quality of life.

Authors: Wintraecken VM van Roozendaal LM Simons JM et al.

Source: The British journal of surgery [Br J Surg] 2025 Apr 30; Vol. 112 (5).

Publication Type: Equivalence Trial; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Oxford University Press on behalf of BJS Foundation Ltd Country of Publication: England NLM ID: 0372553 Publication Model: Print Cited Medium: Internet ISSN: 1365-2168 (Electronic) Linking ISSN: 00071323 NLM ISO Abbreviation: Br J Surg Subsets: MEDLINE

Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.

Authors: Richters L Gluz O Weber-Lassalle N et al.

Source: JAMA network open [JAMA Netw Open] 2025 Feb 03; Vol. 8 (2), pp. e2461639. Date of Electronic Publication: 2025 Feb 03.

Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE

Prognostic value of immunohistochemical markers of intratumoral hypoxia in pregnancy-associated breast cancer.

Authors: Bakhuis CFJ van Diest PJ Suelmann BBM et al.

Source: Journal of clinical pathology [J Clin Pathol] 2025 Dec 15; Vol. 79 (1), pp. 57-64. Date of Electronic Publication: 2025 Dec 15.

Publication Type: Journal Article

Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 0376601 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-4146 (Electronic) Linking ISSN: 00219746 NLM ISO Abbreviation: J Clin Pathol Subsets: MEDLINE

Decision-making in breast pathology reporting: the effect of clinical relevant thresholds.

Authors: Kain ZE Baez-Navarro X Linn SC et al.

Source: Histopathology [Histopathology] 2025 Dec; Vol. 87 (6), pp. 951-955. Date of Electronic Publication: 2025 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7704136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2559 (Electronic) Linking ISSN: 03090167 NLM ISO Abbreviation: Histopathology Subsets: MEDLINE

Pathological complete response and survival after neoadjuvant chemotherapy in patients with stage I TNBC: a registry-based study.

Authors: de Graaf M Gielen RCAM Balduzzi S et al.

Source: ESMO open [ESMO Open] 2025 Dec; Vol. 10 (12), pp. 105923. Date of Electronic Publication: 2025 Dec 05.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancer.

Authors: Schirris Y Voorthuis R Opdam M et al.

Source: The Lancet. Digital health [Lancet Digit Health] 2025 Nov; Vol. 7 (11), pp. 100921. Date of Electronic Publication: 2025 Dec 10.

Publication Type: Journal Article; Multicenter Study; Validation Study

Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101751302 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2589-7500 (Electronic) Linking ISSN: 25897500 NLM ISO Abbreviation: Lancet Digit Health Subsets: MEDLINE

Worse prognosis for breast cancer diagnosed in advanced pregnancy and shortly postpartum: an update of the Dutch pregnancy-associated breast cancer cohort.

Authors: Bakhuis CFJ Preković S Suelmann BBM et al.

Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Nov; Vol. 214 (2), pp. 191-204. Date of Electronic Publication: 2025 Aug 12.

Publication Type: Journal Article

Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE